Infinitopes Precision Immunomics
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$70.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Infinitopes Precision Immunomics is a biotechnology company that develops precision cancer vaccines using its proprietary antigen discovery platform and viral vector delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinitopes Precision Immunomics Comparables
Compare Infinitopes Precision Immunomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| myNEO Therapeutics | 83% | |
| Epitopea | 79% | |
| Nouscom | 79% | |
Infinitopes Precision Immunomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2026 | ||||
| Seed | Apr 30, 2024 |
Key People
Founding team and executive leadership
Infinitopes Precision Immunomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| Cancer Research Horizons | Seed |
| Saras Capital | Seed |
| Meltwind Advisory | Seed |
| Kindred Capital | Seed |
| Amplify Partners | Seed |
| Manta Ray Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
$35.1M raised in Seed funding.
- Mar 20, 2025
Jo Brewer appointed as Non-Executive Director
Infinitopes Precision Immunomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Infinitopes Precision Immunomics's valuation, stock price, and market status.